Jiangxi Fushine Pharmaceutical (300497.SZ) establishes a wholly-owned subsidiary, Fuxiang (Fuyu) Biotechnology.

25/02/2025

GMT Eight

Jiangxi Fushine Pharmaceutical (300497.SZ) announced that the company has established Fuxiang (Fuyu) Biological Technology Co., Ltd. with its own funds, with a registered capital of 50 million yuan. Recently, Fuxiang (Fuyu) Biological Technology Co., Ltd. has completed the industrial and commercial registration procedures and obtained the "Business License" issued by the Fuyu County Market Supervision Administration.

BEISEN HOLDING (09669) subscribed to a wealth management product worth 110 million yuan.

Zhongtian Service (002188.SZ) announced its annual performance for 2024, with a net profit of 7.08 million yuan, a year-on-year decrease of 64.98%.

Contact: contact@gmteight.com

Jiangxi Fushine Pharmaceutical (300497.SZ) establishes a wholly-owned subsidiary, Fuxiang (Fuyu) Biotechnology.

RECOMMEND

Hefei I-TEK OptoElectronics (688610.SH): Net profit in 2024 was 15.75 million yuan, a year-on-year increase of 0.04%.

Morgan Stanley predicts that a wave of cooperation between Chinese and American electric vehicle companies will begin, leading to a "reassessment of value" for US car companies.

WEIHAI BANK (09677) name changed to "WEIHAI BANK Limited Company"